Evidence map›Paper›PMID 35382503›Full record

ReviewJournal of scleroderma and related disorders2019

Complementary therapies for patients with systemic sclerosis.

Kimberly Showalter, Aileen Hoffmann, Nicole DeCredico, Anjali Thakrar, Esperanza Arroyo, Isaac Goldberg, Monique Hinchcliff

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of scleroderma and related disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. OralMicroorganisms · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kimberly ShowalterNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID https://orcid.org/0000-0001-9343-5545
Aileen HoffmannNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Nicole DeCredicoNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Anjali ThakrarNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Esperanza ArroyoNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Isaac GoldbergNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Monique HinchcliffNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Northwestern University · US

Funding

Predictive Ability of Gene Expression Signatures In Skin as SSc BiomarkersK23AR059763 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HINCHCLIFF, MONIQUE EVANGELINE · 2013 to 2015
$390k
NIAMS NIH HHS K23 AR059763
6 · The paper itself

Abstract

Patients with systemic sclerosis often seek information regarding complementary and nutrition-based therapy. Some study results have shown that vitamins D and E, probiotics, turmeric, l-arginine, essential fatty acids, broccoli, biofeedback, and acupuncture may be beneficial in systemic sclerosis care. However, large randomized clinical trials have not been conducted. This review summarizes current data regarding various complementary therapies in systemic sclerosis and concludes with recommendations.

Indexed as

alternative therapyautoimmune diseasecomplementary therapycurcumindietary supplementnutritionSystemic sclerosisvitamin Dvitamin E

Identifiers

PMID35382503
PMCPMC8922560
OpenAlexW2931660871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.